Joining me today are Carsten Koerl, our CEO; and Craig Felenstein, our CFO. Carsten Koerl: Good morning, everyone, and thank you for joining us today. At the same time, our focus on efficiencies and ...
As research continues into how AI will impact practice, there are open questions about medical training, regulation, and more ...
Each year, University of Toronto professor Laura Tozer updates a slide deck that she presents to her graduate students on the ...
SES offers strong buy potential amid FY25 guidance cuts and leverage concerns. See here for an analysis of SES stock and why we view it as a strong buy opportunity.
Thank you, Ingrid, and good morning. At NovoCure, our mission is to extend survival in some of the most aggressive forms of cancer. Launching tumor treating field's therapy in non-small cell lung ...
Our Culture Mag on MSN
The 25 best EPs of 2025
The question of what constitutes an EP did not go away in 2025. A certain artist who topped our EPs list several years ago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback